Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,433 | -17,180 | -3,174 | -11,694 | -52,339 |
| Depreciation Amortization | 613 | 453 | 284 | 136 | 568 |
| Accounts payable and accrued liabilities | -512 | -993 | 1,017 | -107 | 1,750 |
| Other Working Capital | -150 | 703 | 2,448 | -1,740 | 2,386 |
| Other Operating Activity | -29,474 | -28,931 | -31,516 | -3,281 | 1,854 |
| Operating Cash Flow | $-55,956 | $-45,948 | $-30,941 | $-16,686 | $-45,781 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 54,754 | 33,467 | 33,179 | 20,207 | 7,557 |
| PPE Investments | -71 | -49 | -53 | -19 | -40 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -10,000 |
| Purchase Sale Intangibles | -90 | -116 | -116 | N/A | -97 |
| Other Investing Activity | -89 | -116 | -116 | 0 | -98 |
| Investing Cash Flow | $54,594 | $33,302 | $33,010 | $20,188 | $-2,581 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 622 | 622 | 584 | 228 | 535 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 30,000 |
| Financing Cash Flow | $622 | $622 | $584 | $228 | $30,535 |
| Beginning Cash Position | 28,972 | 28,972 | 28,972 | 28,972 | 46,799 |
| End Cash Position | 28,232 | 16,948 | 31,625 | 32,703 | 28,972 |
| Net Cash Flow | $-740 | $-12,024 | $2,653 | $3,731 | $-17,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,956 | -45,948 | -30,941 | -16,686 | -45,781 |
| Capital Expenditure | -71 | -49 | -53 | -19 | -40 |
| Free Cash Flow | -56,027 | -45,997 | -30,994 | -16,705 | -45,821 |